¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ $4DFgvy$  
f( ]R/'o  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© ^I@ey*$  
==nYe { 2  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ?E%U|(S)=L  
#!w:_T%  
1.Co-stimulators (or co-stimulating molecules) lr`?yn1D(  
4xv9a;fP  
2.NK-kB Uc\|X;nkRk  
Jz=;mrW  
3.Immunoglobulin superfamily B"7$!Co  
)\um "l*\c  
4.antigen-presenting cell (APC) C]yvK}  
]&&I|K_  
5.death domain 2ZU@>W  
NdM}xh  
6.CCR and CXCR 2dv|6p  
)W[KD,0+j  
7.Lectin (or mitogen) `DI{wqV9  
h{Oz*Bq  
8.Clusters of differentiation, CD) b%=1"&JI:  
[ P.@1mV  
9.B7 family 29R_n)ne  
~+nS)4 (  
10.Cytotoxic T lymphocyte, CTL) Hi9 G^Q  
=@bXGMsV!  
11.IL-15 and IL-15 receptor (IL-15R) Q.j-C}a  
] +}:VaeA  
12.MHC restriction 2z.k)Qx!Z  
F7k4C2r  
13.Affinity-chromatography j zxf"X-  
[{6&.v  
14.Cyctosprin A, CsA &M!4]p ow  
T+ &x{+gZ  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) B| $\/xO  
5O;/ lX!u  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 8.Pcr<  
}0k"Sw X  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 +=n x|:no  
w\0Oz?N  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ K1m!S9d`x  
~G|{q VO7A  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ 9*G L@_c  
?X8K$g  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© ~Mg8C9B?%3  
'W<a54T?z  
ÃâÒßѧרҵ£º !5g)3St  
sT;=7 L<TA  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ _js2^ <7v}  
a$ +e8>  
Ïû»¯ÄÚ¿Æ£º 8KtF<`A)  
'vf,T4uQ"  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ rRA_'t;uK  
`9G$p|6  
ѪҺ²¡Ñ§×¨Òµ£º z- {"pI  
0X S' v,|  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
5+2=? ÕýÈ·´ð°¸:7
°´"Ctrl+Enter"Ö±½ÓÌá½»